18039

540025

ADVENZYMES

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ADVANCED ENZYME TECH LTD Share Price Today

ADVANCED ENZYME TECH LTD is currently trading at ₹369.25, down by ₹3.54 from the previous close. The stock touched an intraday high of ₹374.80 and a low of ₹369.05 during the latest trading session. Over the past one year, ADVANCED ENZYME TECH LTD has delivered a return of 8.52%, while the stock has gained 2.48% in the last one month.

ADVANCED ENZYME TECH LTD performance

Today’s low Today’s high
₹ 369.05 ₹ 374.80
₹ 372.80
52 week low 52 week high
₹ 251.95 ₹ 419.00
₹ 372.80
Open Price ₹ 374.80
Prev. Close ₹ 372.80
Volume (Shares) 96441.00
Total traded value ₹ 359.53
Upper Circuit ₹ 447.35
Lower Circuit ₹ 298.25
info

Investment Returns

Over 1 Month 2.48% Over 3 Months 32.81% Over 6 Months 22.83% Over 1 Year 8.52%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ADVANCED ENZYME TECH LTD fundamentals


  • Market cap (Cr) 4,174.50
  • P/E Ratio (TTM) 31.77
  • Beta 0.85
  • Book Value / share 63.37
  • Return on equity 16.93%
  • EPS (TTM) 12.06
  • Dividend yield 0.36%
  • Net profit/quarter (Cr) 22.30
info icon alternate text
  • Market cap (Cr) 4,187.30
  • P/E Ratio (TTM) 31.77
  • Beta 0.75
  • Book Value / share 63.37
  • Return on equity 16.93%
  • EPS (TTM) 12.06
  • Dividend yield 0.36%
  • Net profit/quarter (Cr) 22.30
info icon alternate text

ADVANCED ENZYME TECH LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 116.41
Operating Expense 92.73
Net Profit 22.30
Net Profit Margin (%) 19.15
Earnings Per Share (EPS) 1.99
EBITDA 32.01
Effective Tax Rate (%) 22.71
Particulars DEC 2025 (Values in Cr)
Revenue 95.58
Operating Expense 75.21
Net Profit 13.25
Net Profit Margin (%) 13.86
Earnings Per Share (EPS) 1.18
EBITDA 20.91
Effective Tax Rate (%) 25.64
Particulars SEP 2025 (Values in Cr)
Revenue 115.75
Operating Expense 89.21
Net Profit 22.28
Net Profit Margin (%) 19.24
Earnings Per Share (EPS) 1.99
EBITDA 32.67
Effective Tax Rate (%) 24.78
Particulars JUN 2025 (Values in Cr)
Revenue 125.02
Operating Expense 97.48
Net Profit 73.98
Net Profit Margin (%) 59.17
Earnings Per Share (EPS) 6.61
EBITDA 84.38
Effective Tax Rate (%) 9.11
Particulars MAR 2025 (Values in Cr)
Revenue 87.21
Operating Expense 76.23
Net Profit 11.05
Net Profit Margin (%) 12.67
Earnings Per Share (EPS) 0.99
EBITDA 18.70
Effective Tax Rate (%) 28.75
Particulars MAR 2026 (Values in Cr)
Revenue 452.77
Operating Expense 354.63
Net Profit 131.81
Net Profit Margin (%) 29.11
Earnings Per Share (EPS) 11.78
EBITDA 169.96
Effective Tax Rate (%) 16.40
Particulars MAR 2025 (Values in Cr)
Revenue 351.41
Operating Expense 292.38
Net Profit 102.42
Net Profit Margin (%) 29.14
Earnings Per Share (EPS) 9.16
EBITDA 132.18
Effective Tax Rate (%) 15.02
Particulars MAR 2024 (Values in Cr)
Revenue 365.47
Operating Expense 271.34
Net Profit 108.12
Net Profit Margin (%) 29.58
Earnings Per Share (EPS) 9.67
EBITDA 145.05
Effective Tax Rate (%) 19.30
Particulars MAR 2023 (Values in Cr)
Revenue 311.53
Operating Expense 247.05
Net Profit 55.53
Net Profit Margin (%) 17.82
Earnings Per Share (EPS) 4.97
EBITDA 84.70
Effective Tax Rate (%) 25.24
Particulars MAR 2022 (Values in Cr)
Revenue 272.80
Operating Expense 209.81
Net Profit 54.51
Net Profit Margin (%) 19.98
Earnings Per Share (EPS) 4.88
EBITDA 81.72
Effective Tax Rate (%) 24.36
Particulars MAR 2025 (Values in Cr)
Book Value / Share 127.00
ROE % 9.76
ROCE % 13.55
Total Debt to Total Equity 0.03
EBITDA Margin 35.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 118.41
ROE % 10.70
ROCE % 14.53
Total Debt to Total Equity 0.03
EBITDA Margin 36.41
Particulars MAR 2023 (Values in Cr)
Book Value / Share 110.45
ROE % 8.94
ROCE % 12.02
Total Debt to Total Equity 0.03
EBITDA Margin 33.09
Particulars MAR 2022 (Values in Cr)
Book Value / Share 97.37
ROE % 12.02
ROCE % 16.42
Total Debt to Total Equity 0.03
EBITDA Margin 39.48
Particulars MAR 2021 (Values in Cr)
Book Value / Share 86.88
ROE % 16.73
ROCE % 22.79
Total Debt to Total Equity 0.03
EBITDA Margin 48.09
Particulars MAR 2025 (Values in Cr)
Book Value / Share 56.25
ROE % 16.93
ROCE % 19.91
Total Debt to Total Equity 0.00
EBITDA Margin 37.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 51.91
ROE % 22.29
ROCE % 27.61
Total Debt to Total Equity 0.00
EBITDA Margin 44.93
Particulars MAR 2023 (Values in Cr)
Book Value / Share 46.98
ROE % 11.04
ROCE % 14.76
Total Debt to Total Equity 0.00
EBITDA Margin 27.25
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.97
ROE % 11.90
ROCE % 15.72
Total Debt to Total Equity 0.00
EBITDA Margin 30.02
Particulars MAR 2021 (Values in Cr)
Book Value / Share 38.97
ROE % 17.62
ROCE % 23.94
Total Debt to Total Equity 0.01
EBITDA Margin 37.95
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 107.68
Total Assets 1621.34
Total Liabilities 1621.34
Total Equity 1468.67
Share Outstanding 11
Price to Book Ratio 4.96
Return on Assets (%) 8.08
Return on Capital (%) 8.8
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 126.94
Total Assets 1535.46
Total Liabilities 1535.46
Total Equity 1371.08
Share Outstanding 11
Price to Book Ratio 6.69
Return on Assets (%) 8.68
Return on Capital (%) 9.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 123.34
Total Assets 1421.84
Total Liabilities 1421.84
Total Equity 1284.17
Share Outstanding 11
Price to Book Ratio 4.93
Return on Assets (%) 7.42
Return on Capital (%) 8.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 273.63
Total Assets 1267.60
Total Liabilities 1267.60
Total Equity 1140.38
Share Outstanding 11
Price to Book Ratio 6.57
Return on Assets (%) 9.43
Return on Capital (%) 10.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 197.77
Total Assets 1152.67
Total Liabilities 1152.67
Total Equity 1030.76
Share Outstanding 11
Price to Book Ratio 8.85
Return on Assets (%) 12.68
Return on Capital (%) 13.99
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 5.83
Total Assets 688.63
Total Liabilities 688.63
Total Equity 629.34
Share Outstanding 11
Price to Book Ratio 4.96
Return on Assets (%) 14.87
Return on Capital (%) 16.27
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.01
Total Assets 632.93
Total Liabilities 632.93
Total Equity 580.47
Share Outstanding 11
Price to Book Ratio 6.69
Return on Assets (%) 17.08
Return on Capital (%) 18.63
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 24.72
Total Assets 575.80
Total Liabilities 575.80
Total Equity 525.33
Share Outstanding 11
Price to Book Ratio 4.93
Return on Assets (%) 9.64
Return on Capital (%) 10.57
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.97
Total Assets 529.62
Total Liabilities 529.62
Total Equity 480.35
Share Outstanding 11
Price to Book Ratio 6.57
Return on Assets (%) 10.29
Return on Capital (%) 11.34
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.87
Total Assets 489.60
Total Liabilities 489.60
Total Equity 435.44
Share Outstanding 11
Price to Book Ratio 8.85
Return on Assets (%) 14.50
Return on Capital (%) 16.27
Particulars MAR 2025 (Values in Cr)
Net Income 187.36
Cash from Operations 202.17
Cash from Investing -89.10
Cash from Financing -72.54
Net change in Cash -19.14
Free Cash Flow 235.97
Particulars MAR 2024 (Values in Cr)
Net Income 187.82
Cash from Operations 190.60
Cash from Investing -64.64
Cash from Financing -59.23
Net change in Cash 17.48
Free Cash Flow 237.86
Particulars MAR 2023 (Values in Cr)
Net Income 140.38
Cash from Operations 177.00
Cash from Investing -298.18
Cash from Financing -25.79
Net change in Cash -183.61
Free Cash Flow 215.10
Particulars MAR 2022 (Values in Cr)
Net Income 171.05
Cash from Operations 176.82
Cash from Investing -3.78
Cash from Financing -48.50
Net change in Cash 70.00
Free Cash Flow 204.93
Particulars MAR 2021 (Values in Cr)
Net Income 210.37
Cash from Operations 219.60
Cash from Investing -26.03
Cash from Financing -26.31
Net change in Cash 110.54
Free Cash Flow 239.04
Particulars MAR 2025 (Values in Cr)
Net Income 120.52
Cash from Operations 85.02
Cash from Investing -1.73
Cash from Financing -57.63
Net change in Cash 4.10
Free Cash Flow 107.36
Particulars MAR 2024 (Values in Cr)
Net Income 133.99
Cash from Operations 78.83
Cash from Investing -2.70
Cash from Financing -56.88
Net change in Cash -7.95
Free Cash Flow 99.44
Particulars MAR 2023 (Values in Cr)
Net Income 74.27
Cash from Operations 66.75
Cash from Investing -42.35
Cash from Financing -11.99
Net change in Cash -4.04
Free Cash Flow 90.17
Particulars MAR 2022 (Values in Cr)
Net Income 72.07
Cash from Operations 58.54
Cash from Investing -14.23
Cash from Financing -10.87
Net change in Cash 11.99
Free Cash Flow 69.08
Particulars MAR 2021 (Values in Cr)
Net Income 98.42
Cash from Operations 111.01
Cash from Investing -69.90
Cash from Financing -15.44
Net change in Cash -1.16
Free Cash Flow 120.48
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 13.46 1.57 249.59 23.12 38.85
BLISS GVS PHARMA LTD. 474.55 38.52 4.21 5032.90 118.35 477.30
CIPLA LTD 1350.75 28.67 3.16 109119.71 1165.55 1672.20
FERMENTA BIOTECH LTD. 321.70 14.19 2.32 946.79 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 32.57 22.78 4.19 249.59 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 536.40 24.04 4.18 1550.77 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8520.60 111.28 24.40 21301.50 7630.00 10395.35
BLISS GVS PHARMA LTD. 474.55 51.19 4.35 5032.90 118.35 477.30

ADVANCED ENZYME TECH LTD shareholding pattern

Holding
25.83%
43.26%
25.49%
5.41%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ADVANCED ENZYME TECH LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
372.80 0.00 redarrow
red-green-graph indicator
2 Bearish
14 Bullish
  • 5 Days 369.90
  • 26 Days 366.10
  • 10 Days 370.50
  • 50 Days 351.40
  • 12 Days 370.70
  • 100 Days 333.00
  • 20 Days 369.10
  • 200 Days 325.80
367.08 PIVOT
First Support 364.27 First Resistance 371.37 Second Support 359.98 Second Resistance 374.18 Third Support 357.17 Third Resistance 378.47
RSI 54.69 ADX 25.07 MACD 4.60 Williams % R -60.79 Commodity Channel Index (CCI) -44.69
Date 2026-06-17 Week 52306.00 Same Day 48875.00 Month 83763.00
1 Year 0.86 3 Year 0.87
Over 1 Month
2.48% down
Over 1 Year
8.52% down
Over 3 Months
32.81% down
Over 3 Years
10.84% down
Over 6 Months
22.83% down
Over 5 Years
-2.90% down

ADVANCED ENZYME TECH LTD Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
23 Jul 2025 1.2 Final 23 Jul 2025 Equity shares
16 May 2025 4.0 Interim 17 May 2025 Equity shares
18 Jul 2024 1.1 Final 18 Jul 2024 Equity shares
17 May 2024 4.0 Interim 18 May 2024 Equity shares
04 Aug 2023 1.0 Final 05 Aug 2023 Equity shares
19 May 2023 4.0 Interim 20 May 2023 Equity shares
11 Aug 2022 1.0 Final 12 Aug 2022 Equity shares
31 Aug 2021 0.9 Final 01 Sep 2021 Equity shares
09 Jul 2020 0.6 Final 11 Jul 2020 Equity shares
01 Aug 2019 0.6 Final 03 Aug 2019 Equity shares
06 Sep 2018 0.5 Final 08 Sep 2018 Equity shares
04 Sep 2017 0.4 Final 06 Sep 2017 Equity shares
Ex-Date Old FV NEW FV Record Date
25 May 2017 10.0 2.0 26 May 2017
Dividend date Dividend amount Dividend type Record date Instrument type
23 Jul 2025 1.2 Final 23 Jul 2025 Equity shares
16 May 2025 4.0 Interim 17 May 2025 Equity shares
18 Jul 2024 1.1 Final 18 Jul 2024 Equity shares
17 May 2024 4.0 Interim 18 May 2024 Equity shares
04 Aug 2023 1.0 Final 05 Aug 2023 Equity shares
19 May 2023 4.0 Interim 20 May 2023 Equity shares
11 Aug 2022 1.0 Final 12 Aug 2022 Equity shares
31 Aug 2021 0.9 Final 01 Sep 2021 Equity shares
09 Jul 2020 0.6 Final 11 Jul 2020 Equity shares
01 Aug 2019 0.6 Final 03 Aug 2019 Equity shares
06 Sep 2018 0.5 Final 08 Sep 2018 Equity shares
04 Sep 2017 0.4 Final 06 Sep 2017 Equity shares
Ex-Date Old FV NEW FV Record Date
25 May 2017 10.0 2.0 26 May 2017

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Advanced Enzyme Technologies Ltd?

Answer Field

Advanced Enzyme Technologies Ltd share price is for NSE ₹ 369.25 & for BSE ₹ 369.65 as on Jun 18 2026 10:49 AM.

What is the Market Cap of Advanced Enzyme Technologies Ltd Share?

Answer Field

The market cap of Advanced Enzyme Technologies Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 18 2026 10:49 AM.

What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?

Answer Field

The 52 Week High and Low of Advanced Enzyme Technologies Ltd for NSE is ₹ 419.00 and ₹ 251.95 and for BSE is ₹ 419.80 and ₹ 251.90.

What is 1 year return for Advanced Enzyme Technologies Ltd?

Answer Field

The 1 year returns on the stock has been 8.52%.

What is the P/E Ratio of Advanced Enzyme Technologies Ltd Share?

Answer Field

As on Jun 18 2026 10:49 AM the price-to-earnings (PE) ratio for Advanced Enzyme Technologies Ltd share is 31.77.

What is the PB ratio of Advanced Enzyme Technologies Ltd Share?

Answer Field

As on Jun 18 2026 10:49 AM, the price-to-book (PB) ratio for Advanced Enzyme Technologies Ltd share is 63.37.

How to Buy Advanced Enzyme Technologies Ltd Share?

Answer Field

You can trade in Advanced Enzyme Technologies Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Advanced Enzyme Technologies Ltd Share on Bajaj Broking App?

Answer Field

To buy Advanced Enzyme Technologies Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Advanced Enzyme Technologies Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|